191 related articles for article (PubMed ID: 7544303)
21. Induction of megakaryocytopoiesis and thrombocytopoiesis by JTZ-132, a novel small molecule with thrombopoietin mimetic activities.
Inagaki K; Oda T; Naka Y; Shinkai H; Komatsu N; Iwamura H
Blood; 2004 Jul; 104(1):58-64. PubMed ID: 15001470
[TBL] [Abstract][Full Text] [Related]
22. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl.
Broudy VC; Lin NL
Cytokine; 2004 Jan; 25(2):52-60. PubMed ID: 14693160
[TBL] [Abstract][Full Text] [Related]
23. TPO/c-mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products, Vav and c-Cbl, and Ras signaling molecules.
Sasaki K; Odai H; Hanazono Y; Ueno H; Ogawa S; Langdon WY; Tanaka T; Miyagawa K; Mitani K; Yazaki Y
Biochem Biophys Res Commun; 1995 Nov; 216(1):338-47. PubMed ID: 7488109
[TBL] [Abstract][Full Text] [Related]
24. Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase, JAK2.
Tortolani PJ; Johnston JA; Bacon CM; McVicar DW; Shimosaka A; Linnekin D; Longo DL; O'Shea JJ
Blood; 1995 Jun; 85(12):3444-51. PubMed ID: 7780132
[TBL] [Abstract][Full Text] [Related]
25. Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro.
Ezumi Y; Takayama H; Okuma M
FEBS Lett; 1995 Oct; 374(1):48-52. PubMed ID: 7589510
[TBL] [Abstract][Full Text] [Related]
26. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
Tong W; Lodish HF
J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
[TBL] [Abstract][Full Text] [Related]
27. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
28. Thrombopoietin supports in vitro erythroid differentiation via its specific receptor c-Mpl in a human leukemia cell line.
Yamada M; Komatsu N; Kirito K; Kashii Y; Tomizuka H; Okada K; Endo T; Fukumaki Y; Shinjo K; Abe K; Miura Y
Cell Growth Differ; 1998 Jun; 9(6):487-96. PubMed ID: 9663467
[TBL] [Abstract][Full Text] [Related]
29. A non-peptide compound which can mimic the effect of thrombopoietin via c-Mpl.
Kimura T; Kaburaki H; Tsujino T; Ikeda Y; Kato H; Watanabe Y
FEBS Lett; 1998 May; 428(3):250-4. PubMed ID: 9654143
[TBL] [Abstract][Full Text] [Related]
30. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
31. Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways.
Doshi PD; Giri JG; Abegg AL; Favara JP; Huynh MS; Kahn LE; Minnerly JC; Pegg LE; Villani-Price D; Siegel NR; Staten NR; Thomas JW; McKearn JP; Smith WG
Exp Hematol; 2001 Oct; 29(10):1177-84. PubMed ID: 11602319
[TBL] [Abstract][Full Text] [Related]
32. Thrombopoietin and its receptor.
Wendling F; Vainchenker W
Eur Cytokine Netw; 1998 Sep; 9(3):221-31. PubMed ID: 9831170
[TBL] [Abstract][Full Text] [Related]
33. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism.
Brizzi MF; Battaglia E; Montrucchio G; Dentelli P; Del Sorbo L; Garbarino G; Pegoraro L; Camussi G
Circ Res; 1999 Apr; 84(7):785-96. PubMed ID: 10205146
[TBL] [Abstract][Full Text] [Related]
34. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
Johnston JA; Bacon CM; Finbloom DS; Rees RC; Kaplan D; Shibuya K; Ortaldo JR; Gupta S; Chen YQ; Giri JD
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8705-9. PubMed ID: 7568001
[TBL] [Abstract][Full Text] [Related]
35. A novel MPL point mutation resulting in thrombopoietin-independent activation.
Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
[TBL] [Abstract][Full Text] [Related]
36. In vitro interaction between STAT 5 and JAK 2; dependence upon phosphorylation status of STAT 5 and JAK 2.
Flores-Morales A; Pircher TJ; Silvennoinen O; Gustafsson JA; Sanchez-Gomez M; Norstedt G; Haldosén LA; Wood TJ
Mol Cell Endocrinol; 1998 Mar; 138(1-2):1-10. PubMed ID: 9685210
[TBL] [Abstract][Full Text] [Related]
37. Thrombopoietin induces association of Crkl with STAT5 but not STAT3 in human platelets.
Ozaki K; Oda A; Wakao H; Rhodes J; Druker BJ; Ishida A; Wakui M; Okamoto S; Morita K; Handa M; Komatsu N; Ohashi H; Miyajima A; Ikeda Y
Blood; 1998 Dec; 92(12):4652-62. PubMed ID: 9845531
[TBL] [Abstract][Full Text] [Related]
38. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor.
Sotiropoulos A; Moutoussamy S; Renaudie F; Clauss M; Kayser C; Gouilleux F; Kelly PA; Finidori J
Mol Endocrinol; 1996 Aug; 10(8):998-1009. PubMed ID: 8843416
[TBL] [Abstract][Full Text] [Related]
39. Thrombopoietin induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in a human thrombopoietin-dependent cell line.
Yamada M; Komatsu N; Okada K; Kato T; Miyazaki H; Miura Y
Biochem Biophys Res Commun; 1995 Dec; 217(1):230-7. PubMed ID: 8526916
[TBL] [Abstract][Full Text] [Related]
40. An epidermal growth factor receptor/Jak2 tyrosine kinase domain chimera induces tyrosine phosphorylation of Stat5 and transduces a growth signal in hematopoietic cells.
Nakamura N; Chin H; Miyasaka N; Miura O
J Biol Chem; 1996 Aug; 271(32):19483-8. PubMed ID: 8702638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
